Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

CMAJ Podcasts

How to pay for Canadian pharmacare

26 Nov 2018

Description

Canada has long been the only high-income country with a universal health insurance system that excludes universal coverage of prescription drugs. In this podcast, Steve Morgan and Michael Wolfson, two prominent health policy and economics researchers, propose a detailed funding model for national pharmacare that would result in savings. Steve Morgan is a professor of health policy in the School of Population and Public Health at the University of British Columbia. He has studied prescription drug coverage and pricing policies for many years.Michael Wolfson is adjunct professor in the School of Epidemiology and Public Health at the University of Ottawa and was Assistant Chief Statistician a Statistics Canada up until his retirement in 2009.They co-wrote an analysis article published in the Canadian Medical Association Journal.Full analysis article: www.cmaj.ca/lookup/doi/10.1503/cmaj.180897To request a transcript of this podcast, contact [email protected] to CMAJ Podcasts on Apple Podcasts or your favourite podcast app. You can also follow us directly on our SoundCloud page or you can visit www.cmaj.ca/page/multimedia/podcasts.Comments or questions? Text us.Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.You can find Blair and Mojola on X @BlairBigham and @DrmojolaomoleX (in English): @CMAJ X (en français): @JAMC FacebookInstagram: @CMAJ.ca The CMAJ Podcast is produced by PodCraft Productions

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.